Advertisement

Enviromental Impact and Risk of CAFOs

  • Amy Pruden
  • Laurence Shore
Chapter
Part of the Emerging Topics in Ecotoxicology book series (ETEP, volume 1)

Abstract

Although effects of compounds generated from CAFOs on fish and other aquatic organisms have been reported, the unanswered question is if the populations are affected. For the pharmaceuticals, the question is if non-target organism populations are seriously affected, in particular the dung beetle which has positive ecological effects over large areas. The antibiotics are of special concern for the emergence of antibiotic resistance strains. On the other hand, the animals used in domestic husbandry are genetically very similar. For example, all of the cows in Israel are sired from about ten bulls and they are raised in essentially the same 300 cow units. These animals breathe the same and eat many of the same foods and drink the same water as humans. They therefore can be our first line of defense in detecting environmental disruptions. The CAFOs can also be a valuable way of disposing of waste materials from many industries, especially the alcoholic beverages (molasses) and citrus industry (fruit grinds). Poultry manure can be silaged and is a good source of protein and bulk for cattle. Furthermore, the manure produced has become a valuable commodity as interest in organic farming grows and the price of inorganic fertilizers increases.

Keywords

Dung Beetle Poultry Manure Bovine Mastitis Cattle Feedlot Domestic Husbandry 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Aarestrup FM, Jensen LB (1998) Development of penicillin resistance among Staphylococcus aureus isolated from bovine mastitis in Denmark and other countries. Microb Drug Resist 4:247–256CrossRefGoogle Scholar
  2. Aarestrup FM, Jensen LB (2002) Trends in antimicrobial susceptibility in relation to antimicrobial usage and presence of resistance genes in Stapylococcus hyicus isolated from exudative epidermitis in pigs. Vet Microbiol 89:83–94CrossRefGoogle Scholar
  3. Aarestrup FM, Schwarz S (2006) Antimicrobial resistance in staphylococci and streptococci of animal origin. In: Aarestrup FM (ed) Antimicrobial resistance in bacteria of animal origin, ASM Press, Washington, DC, pp 187–212Google Scholar
  4. Aarestrup FM, Seyfarth AM, Emborg HD, Pedersen K, Hendriksen RS, Bager F (2001) Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Animicrob Agent Chemother 45:2054–2059CrossRefGoogle Scholar
  5. Angulo FJ, Griffin PM (2000) Changes in antimicrobial resistance in Salmonella enterica serovar Typhimurium. Emerg Infect Dis 6:436–437CrossRefGoogle Scholar
  6. Bates J, Jordens Z, Selkon JB (1993) Evidence for an animal origin of vancomycin-resistant enterococci. Lancet 342:490–491CrossRefGoogle Scholar
  7. Brugère C, Ridler N (2004) Global aquaculture outlook in the next decades: an analysis of national aquaculture production forecasts to 2030. FAO Fisheries Circular, No. 1001, Rome, FAOGoogle Scholar
  8. Cloeckaert A, Schwarz S (2001) Molecular characterization, spread and evolution of multidrug resistance in Salmonella enterica typhimurium DT104. Vet Res. 32:301–310CrossRefGoogle Scholar
  9. CVM (Center for Veterinary Medicine) (2001) U.S. FDA CVM: The human health impact of fluoroquinolone-resistant Campylobacter attributed to the consumption of chicken. Revised January 5, 2001Google Scholar
  10. Dantas G, Sommer MOA, Oluwasegun RD, Church GM (2008) Bacteria subsisting on antibiotics. Science 320:100–103CrossRefGoogle Scholar
  11. De Liguoro M, Cibin V, Capolongo F, Halling-Sørensen B, Montesissa C (2003) Use of oxytetracycline and tylosin in intensive calf farming: evaluation of transfer to manure and soil. Chemosphere 52:203–212CrossRefGoogle Scholar
  12. Donabedian SM, Thal A, Hershberger E, Perri MB, Chow JW, Bartlett P, Jones R, Joyce K, Rossiter S, Gay K, Johnson J, Mackinson C, Debess E, Madden J, Angulo F, Zervos MJ (2003) Molecular characterization of gentamicin-resistant enterococci in the United States: evidence of spread from animals to humans through food. J Clin Microbiol 41:1109–1113CrossRefGoogle Scholar
  13. Emborg HD, Ersboll AK, Heuer OE, Wegener HC (2001) The effect of discontinuing the use of antimicrobial growth promoters on the productivity in the Danish broiler production. Prev Vet Med 50:53–70CrossRefGoogle Scholar
  14. Endtz HP, Ruijs GJ, van Klingeren B, Jansen WH, van der Reyden T, Mouton RP (1991) Quinolone resistance in Campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J Antimicrob Chemother 27:199–208CrossRefGoogle Scholar
  15. Fontenot JP, Ayangbile GA, Allen VG (1996) Potential for recycling animal wastes by feeding to reduce environmental contamination. In: Kornegay IT (ed) Nutrient management of food animals to enhance and protect the environment. CRC Press, Boca Raton FL pp 199–217Google Scholar
  16. Food and Drug Administration Department of Health and Human Services (USFDA) (2006) Withdrawal of approval of the new animal drug application for enrofloxacin in poultry. Docket No 200N-1571Google Scholar
  17. Graham JP, Boland JJ, Silbergeld E (2007) Growth promoting antibiotics in food animal production: an economic analysis. Pub Health Rep 122:79–87Google Scholar
  18. Hammerum AM, Heuer OE, Lester CH, Agerso Y, Seyfarth AM, Emborg HD, Frimodt-Moller N, Monnet DL (2007) Comment on: withdrawal of growth-promoting antibiotics in Europe and its effects in relation to human health. Intl J Antimicrob Agent 30:466–468CrossRefGoogle Scholar
  19. Hamscher G, Sczesny S, Höper H, Nau H (2002) Determination of persistent tetracycline residues in soil fertilized with liquid manure by high-performance liquid chromatography with electrospray ionization tandem mass spectrometry. Anal Chem 74:1509–1518CrossRefGoogle Scholar
  20. Harborne JB (1997) Recent advances in chemical ecology. Nat Prod Rep 14:83–98CrossRefGoogle Scholar
  21. Huggert DB, Ericson JF, Cook JC, Williams RT (2004) Plasma concentrations of human pharmaceuticals as predictors of pharmacological responses in fish. In: Kümmerer K (ed) Pharmaceuticals in the environment. Sources, fate, effects and risks, 2nd edn. Springer-Verlag, Heidelberg, pp 373–386Google Scholar
  22. Irwin LK, Gray SL, Oberdorster E (2001) Vitellogenin induction in painted turtle, Chrysemys picta, as a biomarker of exposure to environmental levels of estradiol. Aquat Toxicol 55:49–60CrossRefGoogle Scholar
  23. Kemper N, Färber H, Sklutlarek D, Krieter J (2008) Analysis of antibiotic residues in liquid manure and leachate of dairy farms in Northern Germany. Agric Water Manage 95: 1288–1292 CrossRefGoogle Scholar
  24. Kidd KA, Blanchfield PJ, Mills KH, Palace VP, Evans RE, Lazorchak JM, Flick RW (2007) Collapse of a fish population after exposure to a synthetic estrogen. Proc Natl Acad Sci USA 104:8897–8901CrossRefGoogle Scholar
  25. Klare I, Badstubner D, Konstabel C, Bohme G, Claus H, Witte W (1999) Decreased incidence of van A-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry. Microb Drug Resist 5:45–52CrossRefGoogle Scholar
  26. Kotzerke A, Sharma S, Schauss K, Heuer H, Thiele-Bruhn S, Smalla K, Wilke BM, Schloter M (2008) Alterations in soil microbial activity and N-transformation processes due to sulfadiazine loads in pig-manure. Environ Pollut 153:315–322CrossRefGoogle Scholar
  27. Krotman Y (2004) Biodiversity and community structure of Jordan system fishes and their relationship to the habitat structure and anthropogenic impact. M.Sc. Thesis, Department of Zoology, Tel Aviv UniversityGoogle Scholar
  28. McEwen SA, Aarestrup FM, Jordan D (2006) Monitoring of antimicrobial resistance in animals: principles and practices. In: Aarestrup FM (ed) Antimicrobial resistance in bacteria of animal origin, ASM Press, Washington DC, pp 397–413Google Scholar
  29. Orlando EF, Kolok AS, Binzcik GA, Gates JL, Horton MK, Lambright CS, Gray Jr LE, Soto AM, Guilette LJ Jr (2004) Endocrine-disrupting effects of cattle feedlot effluent on an aquatic sentinel species, the fathead minnow. Environ Health Perspect 12:1–9Google Scholar
  30. Palace VP, Wautier KG, Evans RE, Blanchfield PJ, Mills KH, Chalanchuk SM, Godard D, McMaster ME, Tetreault GR, Peters LE, Vandenbyllaardt L, Kidd KA (2006) Biochemical and histopathological effects in pearl dace (Margariscus margarita) chronically exposed to a synthetic estrogen in a whole lake experiment. Environ Toxicol Chem 25:1114–1125CrossRefGoogle Scholar
  31. Phillips I (2007) Withdrawal of growth-promoting antibiotics in Europe and its effects in relation to human health. Intl J Antimicrob Agent 30:101–107CrossRefGoogle Scholar
  32. Phillips I (2008) Withdrawal of growth-promoting antibiotics: comments on commentary. Intl J Antimicrob Agent 31:82–83CrossRefGoogle Scholar
  33. Schmitt H, Haapakangas H, van Beelen P (2005) Effects of antibiotics on soil microorganisms: time and nutrients influence pollution-induced community tolerance. Soil Biol Biochem 37:1882–1892CrossRefGoogle Scholar
  34. Simjee S, Jensen LB, Donabedian SM, Zervos MJ (2006) Enterococcus. In: Aarestrup FM (ed) Antimicrobial resistance in bacteria of animal origin. ASM Press, Washington DC, 397–413Google Scholar
  35. Soto AM, Calabro JM, Prechtl NV, Yau AY, Orlando EF, Daxenberger A, Kolok AS, Guillette Jr LJ, le Bizec B, Lange IG, Sonnenschein C (2004) Androgenic and estrogenic activity in water bodies receiving cattle feedlot effluent in eastern Nebraska, USA. Environ Health Perspect 112:346–352CrossRefGoogle Scholar
  36. Speedy AW (2003) Global production and consumption of animal source foods. J Nutr 133:4048 S–4053SGoogle Scholar
  37. Van den Bogaard AE, Bruinsma N, Stobberingh EE (2000) The effect of banning avoparcin on VRE carriage in The Netherlands. J Antimicrol Chemother 46:146–148CrossRefGoogle Scholar
  38. Vose D (2006) Risk assessment and its use in approval, licencing, and prudent use guidelines. In: Aarestrup MF (ed) Antimicrobial Resistance in Bacteria of Animal Origin. ASM Press, Washington, DC 415–424Google Scholar
  39. Wall PG, Morgan D, Lamden K, Griffen M, Threlfall EJ, Rowe B (1995) A case control study of infection with an epidemic strain of multiresistant Salmonella typhimurium DT104 in England and Wales. Communicable Disease Report CDR Review 4 (1994): R130–R135Google Scholar
  40. Webb SF (2004) A data based perspective on the environmental risk assessment of human pharmaceuticals III indirect human exposure. In: Kümmerer K (ed) Pharmaceuticals in the environment. Sources, fate, effects and risks, 2nd edn. Springer-Verlag, Heidelberg 373–386Google Scholar
  41. White DG (2006) Antimicrobial Resistance in pathogenic Escherichia coli from Animals. In: Aarestrup FM (ed) Antimicrobial resistance in bacteria of animal origin. ASM Press, Washington DC 145–166Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Via Department of Civil & Environmental EngineeringVirginia TechBlacksburgUSA

Personalised recommendations